| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | eflornithine (Vaniqa®) |
| Formulation | 11.5% cream |
| Reference number | 120 |
| Indication | Treatment of facial hirsutism in women |
| Company | Shire Pharmaceuticals Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 18/01/2005 |